Helix Biopharma Corp. Press Releases

• Published on March 6, 2025 - 14:00 GMT

  

  Helix Biopharma Corp. Expands Leadership Team with World-Class Oncology and Scientific Experts

  The Company is joined by Thomas Mehrling, MD, PhD as CMO, Jonathan Davis, PhD as Director of ADC Discovery and Davide Guggi, PhD as CTO Helix Biopharma Corp. (TSX:HBP) TORONTO, ONTARIO, CANADA, March 6, 2025 /⁨EINPresswire.com⁩/ -- Helix BioPharma Corp. …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on December 11, 2024 - 14:00 GMT

  Helix Biopharma Corp. Appoints James G. Murphy as Chief Financial Officer

  Mr. Murphy brings over 30 years' experience in finance and operations management in the life sciences. Helix Biopharma Corp. (TSX:HBP) TORONTO, ONTARIO, CANADA, December 11, 2024 /⁨EINPresswire.com⁩/ -- Helix BioPharma Corp. (TSX: “HBP”, OTC PINK: “ …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...
• Published on December 2, 2024 - 23:37 GMT

  Helix Biopharma Corp. Enters into Asset Purchase Agreement to Acquire Oral Gemcitabine Chemotherapy Compound

  The acquistion forms part of an ambitious, yet pragmatic strategy to create a near future where hard-to-treat cancers are less hard-to-treat Helix Biopharma Corp. (TSX:HBP) TORONTO, ONTARIO, CANADA, December 2, 2024 /⁨EINPresswire.com⁩/ -- Helix …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on November 29, 2024 - 15:00 GMT

  Helix Biopharma Corp. Enters Into Asset Purchase Agreement to Acquire Oral Immune Checkpoint Inhibitor

  LR 09 is a novel, patented chemical entity with Orphan Drug Designation from the US Food and Drug Administration (FDA) Helix Biopharma Corp. (TSX:HBP) TORONTO, ONTARIO, CANADA, November 29, 2024 /⁨EINPresswire.com⁩/ -- Helix BioPharma Corp. (TSX: “HBP”, …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...